Portland, OR, June 28, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Smart Insulin Pens Market generated $94.7 million in 2020, and is projected to reach $298.8 million by 2030, witnessing a CAGR of 12.1% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/3485
Surge in incidence of diabetic patients and simple functioning & accuracy related to insulin dosing drive the growth of the global smart insulin pens market. However, there are certain disadvantages associated with the use of insulin pen such as two types of insulin cannot be mixed in an insulin pen, thus increasing the frequency of injections needed. This in turn impedes the smart insulin pens industry growth. The upsurge in demand for smart insulin pens, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for smart insulin pens market size growth.
COVID-19 scenario:
- The outbreak of the COVID-19 pandemic has had a negative impact on the growth of the global smart insulin pens market. Due to the implementation of global lockdown, patients faced difficulty in procuring smart insulin pens due to less production.
- The lockdown further disrupted the whole supply chain, leading to disruptions in the supply of raw materials and hampered the market demand.
The report offers detailed segmentation of the global smart insulin pens market based on type, end user, usability, and region.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/3485?reqfor=covid
Based on end user, the hospital and clinics segment held the highest market share in 2020, holding nearly two-fifths of the total market share, and is expected to continue its leadership status during the forecast period. However, the home care settings segment is estimated to register the highest CAGR of 12.7% from 2021 to 2030.
Report Attribute | Details |
Revenue forecast in 2030 | USD 298.87 Million |
Growth rate | CAGR of 12.1% from 2021 to 2030 |
Forecast period | 2022 - 2030 |
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
Country scope | U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia |
Key companies profiled | Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk, Pendiq, and Sanofi. |
Based on usability, the reusable segment held the largest market share in 2020, holding nearly three-fourths of the total market share, and is expected to continue its leadership status during the forecast period. However, the prefilled segment is projected to register the highest CAGR of 12.5% from 2021 to 2030.
Based on region, Europe contributed to the highest share in terms of revenue in 2020, holding more than two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, LAMEA is projected to manifest the fastest CAGR of 13.4% during the forecast period.
Leading players of the global smart insulin pens market analyzed in the research include Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk, Pendiq, and Sanofi.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.